Sonia Malburg

Sonia Malburg

Investigational interferon-free regimen demonstrates undetectable hepatitis C virus in all patients...

Boehringer Ingelheim - "This collaboration highlights our long-term commitment to developing interferon-free therapeutic options to fulfill unmet needs for patients with HCV, including those who are difficult to treat," said Peter Piliero, M.D., vice president, Clinical Development and Medical Affairs...

Peter Piliero

Mentioned in this article:
Peter Piliero

Phase 3 data show viral cure rates achieved in a broad range of patients with genotype-1 hepatitis C...

... with the Food and Drug Administration," said Peter Piliero, M.D., vice president, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "These results take us a step closer towards our goal of making faldaprevir available for patients who urgently need HCV treatment...

Peter Piliero

Mentioned in this article:
Peter Piliero

Boehringer Ingelheim Announces Phase 3 SVR12 Results in HCV/HIV Co-Infected Patients Treated with Fa...

"The SVR12 data from STARTVerso®4 are encouraging, especially given the inclusion of patients with cirrhosis," said Peter Piliero, MD, vice president, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "Comprehensive data from our STARTVerso® clinical ...

Vansen Pharma Inc. appoints new President and CEO - Yahoo Finance

Boehringer Ingelheim - Dr. Doroudian will join Dr. Patrick Frankham on Vansen's Board of Directors. Dr. Frankham currently serves as "Executive Director, Business Model & Healthcare Innovation" at Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Dr. Frankham has ...

Patrick Frankham

Mentioned in this article:
Patrick Frankham

Allotrope Foundation partners with Osthus Inc. to develop state-of-the-art open framework for labor...

"During the comprehensive and rigorous RFP process, Osthus Inc. kept impressing us with their innovative ideas and intelligent solutions for realizing the concept of Allotrope's framework," said Gordon Hansen, Vice President, Analytical Development at Boehringer Ingelheim and Chair...

Gordon Hansen

Mentioned in this article:
Gordon Hansen

Merck Appoints Simon Sturge as New Head of Biosimilars Unit | Korea IT Times

Darmstadt, Germany - Merck announced today that Simon Sturge (54) will join the company from Boehringer Ingelheim effective March 1, 2014, to head the biosimilars unit. In his new role Sturge will report to Stefan Oschmann, Member of Merck’s Executive Board and responsible for the ...

Simon Sturge

Mentioned in this article:
Simon Sturge

Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising int...

"These results add to the growing body of data for HCV regimens containing our investigational compound, faldaprevir," said Peter Piliero, M.D., vice president, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "We are looking forward to the final ...

With Protections Set to Lapse on Advanced Drugs, U.S. Presses Strict Rules Overseas

Boehringer Ingelheim - Michael Soldan, global head of regulatory affairs for biosimilars at Germany’s Boehringer Ingelheim, compared the process of building a monoclonal antibody to that of building a jet airplane — where simple aspirin would be akin to a bicycle, and simpler biologic compounds like a car. But ...

Michael Soldan

Mentioned in this article:
Michael Soldan

FDA Approves Pradaxa® (dabigatran etexilate mesylate) for Treatment and Reduction in the Risk of Rec...

Boehringer Ingelheim is pleased that patients will now have a new and efficacious therapeutic option for this complex condition," said Sabine Luik, M.D., senior vice president, Medicine & Regulatory Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "This approval is a testament to our ...

Sabine Luik

Mentioned in this article:
Sabine Luik

Boehringer Ingelheim to Sponsor the Bonnie J. Addario Lung Cancer Foundation’s Efforts to Promote Ge...

Boehringer Ingelheim - “Boehringer Ingelheim is honored to be supporting the Bonnie J. Addario Lung Cancer Foundation to help communicate the importance of immediate biomarker testing for patients diagnosed with advanced non-small cell lung cancer,” said Kevin Lokay, vice president and business unit head...

Kevin Lokay

Mentioned in this article:
Kevin Lokay

Join Newsle to find out when Sonia Malburg makes the news.

As a Newsle member, you’ll be able to:

  • Get alerts on Sonia Malburg
  • See news articles & blog posts about Sonia Malburg
  • Follow your friends & colleagues in the news
This profile only includes publicly available information. Questions or comments? Contact Us
Freebase CC-BY
Data from Freebase, licensed under CC-BY
Source: CrunchBase
Data from Wikipedia, licensed under the GFDL